Improvement in Glycemic Control After Left Ventricular Assist Device Implantation in Advanced Heart Failure Patients With Diabetes Mellitus

No abstract is available for this paper.

• Publication year

  2013

• Venue

  ASAIO journal (1992)

• Publication date

  2013-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/MAT.0000000000000127PMID 25232763
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Improvement in Blood Glucose Control in Patients With Diabetes After Implantation of Left Ventricular Assist Devices

  2014cited by this paper
• Reply: To PMID 23219296.

  2013cited by this paper
• Adipose Tissue Inflammation and Adiponectin Resistance in Patients With Advanced Heart Failure: Correction After Ventricular Assist Device Implantation

  2012cited by this paper
• Abstract 15052: Cardiovascular Event Reduction Versus New-Onset Diabetes During Atorvastatin Therapy: Effect of Baseline Risk Factors for Diabetes

  2012cited by this paper
• Deterioration of glucose homeostasis in type 2 diabetic patients one year after beginning of statins therapy.

  2012cited by this paper
• Ventricular Assist Device Implantation Corrects Myocardial Lipotoxicity, Reverses Insulin Resistance, and Normalizes Cardiac Metabolism in Patients With Advanced Heart Failure

  2012cited by this paper
• Improved diabetic control in advanced heart failure patients treated with left ventricular assist devices

  2011cited by this paper
• Hemoglobin variants detected by hemoglobin A1c (HbA1c) analysis and the effects on HbA1c measurements

  2010cited by this paper
• Effect of eplerenone versus spironolactone on cortisol and hemoglobin A₁(c) levels in patients with chronic heart failure.

  2010cited by this paper
• Advanced heart failure treated with continuous-flow left ventricular assist device.

  2009cited by this paper
• Contribution of Impaired Myocardial Insulin Signaling to Mitochondrial Dysfunction and Oxidative Stress in the Heart

  2009cited by this paper
• Insulin resistance is highly prevalent and is associated with reduced exercise tolerance in nondiabetic patients with heart failure.

  2009cited by this paper
• Effect of selective and non-selective beta-blockers on body weight, insulin resistance and leptin concentration in chronic heart failure.

  2008cited by this paper
• Impact of diabetes on outcomes in patients with low and preserved ejection fraction heart failure: an analysis of the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) programme.

  2008cited by this paper
• Effect of selective and non-selective β-blockers on body weight, insulin resistance and leptin concentration in chronic heart failure

  2007cited by this paper
• [Candesartan in heart failure: assessment of reduction in mortality and morbidity].

  2007cited by this paper
• Diabetes in heart failure: prevalence and impact on outcome in the population.

  2006cited by this paper
• Insulin resistance and risk of congestive heart failure.

  2005cited by this paper
• Impaired insulin sensitivity as an independent risk factor for mortality in patients with stable chronic heart failure.

  2005cited by this paper
• Influence of diabetes on the survival of patients hospitalized with heart failure: A 12‐year study

  2005cited by this paper
• Inflammatory cytokine inhibition of erythropoiesis in patients implanted with a mechanical circulatory assist device

  2005cited by this paper
• Effects of Candesartan on the Development of a New Diagnosis of Diabetes Mellitus in Patients With Heart Failure

  2005cited by this paper
• Inflammatory mediated chronic anemia in patients supported with a mechanical circulatory assist device.

  2004cited by this paper
• Insulin resistance and inflammatory activation in older patients with systolic and diastolic heart failure

  2004cited by this paper
• Enalapril reduces the incidence of diabetes in patients with chronic heart failure: insight from the Studies Of Left Ventricular Dysfunction (SOLVD).

  2003cited by this paper
• Interleukin-6 induces cellular insulin resistance in hepatocytes.

  2002cited by this paper
• Myocardial Free Fatty Acid and Glucose Use After Carvedilol Treatment in Patients With Congestive Heart Failure

  2001cited by this paper
• Inflammatory cytokines and the possible immunological role for lipoproteins in chronic heart failure.

  2000cited by this paper
• Insulin resistance in chronic heart failure.

  2000cited by this paper
• Effects of iron deficiency anemia on hemoglobin A1c in type 1 diabetes mellitus

  1999cited by this paper
• Low Serum Cholesterol Levels Predict High Perioperative Mortality in Patients Supported by a Left-Ventricular Assist System

  1998cited by this paper
• Intensity and amount of physical activity in relation to insulin sensitivity: the Insulin Resistance Atherosclerosis Study.

  1998cited by this paper
• Hormonal changes and catabolic/anabolic imbalance in chronic heart failure and their importance for cardiac cachexia.

  1997cited by this paper
• Insulin resistance in chronic heart failure: relation to severity and etiology of heart failure.

  1997cited by this paper
• Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance.

  1995cited by this paper
• Insulin resistance in chronic heart failure.

  1994cited by this paper
• Glycosylated hemoglobins (GHb): an index of red cell survival.

  1982cited by this paper
• Role of diabetes in congestive heart failure: the Framingham study.

  1974cited by this paper

• Impact of Diabetes Mellitus on Outcomes in Patients with Left Ventricular Assist Devices

  2024cites this paper
• Propensity matched post-transplant survival in durable CF-axial pump BTT patients with and without diabetes: A UNOS database analysis

  2024cites this paper
• Metabolic Consequences of Advanced Chronic Heart Failure and its Modification by Implantation of a Durable Left Ventricular Assist Device

  2024cites this paper
• Implantation of Left Ventricular Assist Device Results in Immediate Improvement of Glucose Metabolism in Patients With and Without Diabetes Mellitus.

  2020cites this paper
• What Did We Learn about VADs in 2019?

  2020cites this paper
• Type 2 Diabetes Mellitus and Heart Failure, A Scientific Statement From the American Heart Association and Heart Failure Society of America.

  2019cites this paper
• Type 2 Diabetes Mellitus and Heart Failure: A Scientific Statement From the American Heart Association and the Heart Failure Society of America.

  2019cites this paper
• Influence of Diabetes Mellitus on Outcomes in Patients After Left Ventricular Assist Device Implantation.

  2018cites this paper
• Pharmacotherapy considerations for long‐term management of patients with left ventricular assist devices

  2018cites this paper
• Left ventricular assist device implantation improves glycaemic control: a systematic review and meta‐analysis

  2018cites this paper
• Left ventricular assist device may improve glycemic control in diabetes mellitus patients but the reverse is not true.

  2018cites this paper
• Influence of Diabetes on Outcomes in Patients After Left Ventricular Assist Device Implantation

  2018cites this paper
• Is Diabetes Mellitus a Risk Factor for Poor Outcomes after Left Ventricular Assist Device Placement?

  2017cites this paper
• Outcomes for Patients With Diabetes After Continuous-Flow Left Ventricular Assist Device Implantation.

  2016cites this paper
• Clinical Investigation Outcomes for Patients With Diabetes After Continuous-Flow Left Ventricular Assist Device Implantation

  2016cites this paper
• What Did We Learn About VADs in 2014

  2015cites this paper
• A mathematical model for predicting glucose levels in critically-ill patients: the PIGnOLI model

  2015cites this paper
• World Journal of Diabetes

  year unknowncites this paper